Reduction of intercellular adhesion molecule 1 may play a role in anti-inflammatory effect of hyaluronic acid in a rat model of severe non-bacterial cystitis

World Journal of Urology

Volumn 31, Issue 3, 2013, Pages 535-540

  Shao, Yuan ^a   Lu, Guo liang ^a   Shen, Zhou Jun ^a   He, Hong chao ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

Hyaluronic acid; Intracellular adhesion molecule 1; Mast cell; Non bacterial cystitis; Tumor necrotic factor

Indexed keywords

ANTIINFLAMMATORY AGENT; CYCLOPHOSPHAMIDE; HEPARIN; HYALURONIC ACID; INTERCELLULAR ADHESION MOLECULE 1; LIPOPOLYSACCHARIDE; PROTAMINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BLADDER; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; CYSTITIS; DISEASE MODEL; FEMALE; INTRAVESICAL DRUG ADMINISTRATION; MAST CELL; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME;

ADMINISTRATION, INTRAVESICAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; CYCLOPHOSPHAMIDE; CYSTITIS; DISEASE MODELS, ANIMAL; FEMALE; HEPARIN; HYALURONIC ACID; INTERCELLULAR ADHESION MOLECULE-1; LIPOPOLYSACCHARIDES; MAST CELLS; PROTAMINES; RATS, SPRAGUE-DAWLEY; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; URINARY BLADDER;

EID: 84878229093     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-012-0839-8     Document Type: Article

References (30)

1. Berry SH, Bogart LM, Pham C, Liu K, Nyberg L, Stoto M, Suttorp M, Clemens JQ (2010) Development, validation and testing of an epidemiological case definition of interstitial cystitis/painful bladder syndrome. J Urol 183: 1848-1852.
2. Moldwin RM, Sant GR (2002) Interstitial cystitis: a pathophysiology and treatment update. Clin Obstet Gynecol 45: 259-272.
3. Riedl CR, Engelhardt PF, Daha KL, Morakis N, Pflüger H (2008) Hyaluronan treatment of interstitial cystitis/painful bladder syndrome. Int Urogynecol J 19: 717-721.
4. Ahmad I, Sarath KN, Meddings RN (2008) Sequential hydrodistention and intravesical instillation of hyaluronic acid under general anaesthesia for treatment of refractory interstitial cystitis: a pilot study. Int Urogynecol J 19: 543-546.
5. Nickel JC, Egerdie B, Downey J, Singh R, Skehan A, Carr L, Irvine-Bird K (2009) A real-life multicentre clinical practice study to evaluate the efficacy and safety of intravesical chondroitin sulphate for the treatment of interstitial cystitis. BJU Int 103: 56-60.
6. Shao Y, Shen ZJ, Rui WB, Zhou WL (2010). Intravesical instillation of hyaluronic acid prolonged the effect of bladder hydrodistention in patients with severe interstitial cystitis. Urology 75: 547-550 (author reply 551).
7. Cox PJ (1979) Cyclophosphamide cystitis-identification of acrolein as the causative agent. Biochem Pharmacol 28: 2045-2049.
8. Lanteri-Minet M, Bon K, de Pommery J, Michiels JF, Menétrey D (1995) Cyclophosphamide cystitis as a model of visceral pain in rats: model elaboration and spinal structures involved as revealed by the expression of c-Fos and Krox-24 proteins. Exp Brain Res 105: 220-232.
9. Jerde TJ, Bjorling DE, Steinberg H, Warner T, Saban R (2000) Determination of mouse bladder inflammatory response to E. coli lipopolysaccharide. Urol Res 28: 269-273.
10. Boucher W, Stern JM, Kotsinyan V, Kempuraj D, Papaliodis D, Cohen MS, Theoharides TC (2008) Intravesical nanocrystalline silver decreases experimental bladder inflammation. J Urol 179: 1598-1602.
11. Liu W, Evanoff DP, Chen X, Luo Y (2007) Urinary bladder epithelium antigen induces CD8+ T cell tolerance, activation, and autoimmune response. J Immunol 178: 539-546.
12. Cook EB, Stahl JL, Miller ST, Gern JE, Sukow KA, Graziano FM, Barney NP (1998) Isolation of human conjunctival mast cells and epithelial cells: tumor necrosis factor from mast cells affects intercellular adhesion molecule 1 expression on epithelial cells. Invest Ophthalmol Vis Sci 39: 336-343.
13. Liebert M, Wedemeyer G, Stein JA, Washington R Jr, Faerber G, Flint A, Grossman HB (1993) Evidence for urothelial cell activation in interstitial cystitis. J Urol 149: 470-475.
14. Leppilahti M, Hellström P, Tammela TL (2002) Effect of diagnostic hydrodistension and four intravesical hyaluronic acid instillations on bladder ICAM-1 intensity and association of ICAM-1 intensity with clinical response in patients with interstitial cystitis. Urology 60: 46-51.
15. Bona K, Lantéri-Mineta M, Menétreya D, Berkley KJ (1997) Sex, time-of-day and estrous variations in behavioral and bladder histological consequences of cyclophosphamide-induced cystitis in rats. Pain 73: 423-429.
16. Soler R, Bruschini H, Truzzi JC et al (2008) Urinary glycosaminoglycans excretion and the effect of dimethyl sulfoxide in an experimental model of non-bacterial cystitis. Int Braz J Urol 34: 503-511.
17. Smaldone MC, Vodovotz Y, Tyagi V, Barclay D, Philips BJ, Yoshimura N, Chancellor MB, Tyagi P (2009) Multiplex analysis of urinary cytokine levels in a rat model of cyclophosphamide-induced cystitis. Urology 73: 421-426.
18. Springer TA (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76: 301-314.
19. McCourt PA, Ek B, Forsberg N, Gustafson S (1994) Intercellular adhesion molecule-1 is a cell surface receptor for hyaluronan. J Biol Chem 269: 30081-30084.
20. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA (1986) Induction by IL-1 and interferon-γ tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 137: 245-254.
21. Sato H, Takahashi T, Ide H (1988) Antioxidant activity of synovial fluid, hyaluronic acid and two sub-components of hyaluronic acid: synovial fluid scavenging affect is enhanced in rheumatoid arthritis patients. Arthr Rheum 31: 63-71.
22. Balasz EA, Denlinger JL (1984) The role of hyaluronic acid in arthritis and its therapeutic use. In: Peyron JG (ed) Osteoarthritis. Current clinical and fundamental problems. Geigy, Basel, pp 165-168.
23. Gustafson S, Björkman T, Forsberg N, Lind T, Wikström T, Lidholt K (1995) Accessible hyaluronan receptors identical to ICAM-1 in mouse mast-cell tumors. Glycoconj J 12: 350-355.
24. Green M, Filippou A, Sant G, Theoharides TC (2004) Expression of intercellular adhesion molecules in the bladder of patients with interstitial cystitis. Urology 63: 688-693.
25. Sant GR, Kempuraj D, Marchand JE, Theoharides TC (2007) The mast cell in interstitial cystitis: role in pathophysiology and pathogenesis. Urology 69: 34-40.
26. Larsen MS, Mortensen S, Nordling J, Horn T (2008) Quantifying mast cells in bladder pain syndrome by immunohistochemical analysis. BJU Int 102: 204-207.
27. Theoharides TC, Sant GR (1997) The mast cell as a neuroimmunoendocrine effector in interstitial cystitis. In: Sant GR (ed) Interstitial cystitis. Lippincott-Raven, Philadelphia, pp 101-108.
28. Welker P, Grabbe J, Grützkau A, Henz BM (1998) Effects of nerve growth factor (NGF) and other fibroblast-derived growth factors on immature human mast cells (HMC-1). Immunology 94: 310-317.
29. Boucher WS, Letourneau R, Huang M, Kempuraj D, Green M, Sant GR, Theoharides TC (2002) Intravesical sodium hyaluronate inhibits the rat urinary mast cell mediator increase triggered by acute immobilization stress. J Urol 167: 380-384.
30. Hauser PJ, Buethe DA, Califano J et al (2009) Restoring barrier function to acid damaged bladder by intravesical chondroitin sulfate. J Urol 182: 2477-2482.